Seattle Genetics Will Work It Out – Motley Fool

ThirdAge

Seattle Genetics Will Work It Out Motley Fool A little jittery, are we, Seattle Genetics (Nasdaq: SGEN ) investors? The company gets unanimous recommendations to approve Adcetris, aka brentuximab vedotin, for two different types of lymphomas, yet the stock trades … Seattle Genetics Wins Unanimous OK for Lymphoma Drug from FDA PanelXconomy Oppenheimer Raises PT on Seattle Genetics to $ 24Benzinga SeaGen's Big Day at the FDA, Hutch Nabs $ 20M HIV Grant, Allozyne's Nasdaq Plan …Seattle Post Intelligencer Bizjournals.com -StreetInsider.com (subscription) -Market Intelligence Center all 123 news articles »

Stocks narrowly miss having worst week in a year
A late rally Friday prevented the stock market from having its worst week in nearly a year.
Read more on AP via Yahoo! News

A video tutorial showing you how to use our 100% free website at PerfectStockAlert.com Get free nightly market analysis, tutorial technical analysis videos, stock & ETF picks, access to our trader’s forum, and much more! Visit us today at www.PerfectStockAlert.com
Video Rating: 4 / 5

Seattle Genetics Will Work It Out – Motley Fool ThirdAge Seattle Genetics Will Work It OutMotley FoolA little jittery, are we, Seattle Genetics (Nasdaq: SGEN ) investors? The company gets unanimous recommendations to approve Adcetris, aka brentuximab vedotin, for two different types of lymphomas, yet the stock trades …Seattle Genetics Wins Unanimous OK for Lymphoma [...]